Skip to content, Open navigation or Skip to contact information.

Copyright © Inderes 2011 - present. All rights reserved.
Latest
Markets
Stock Comparison
Calendar
Research
Articles
Insider transactions
inderesTV
Portfolio
Forum
About us
Our coverage
Team
Settings
Copyright © Inderes 2011 - present. All rights reserved.
Claus Thestrup portrait

Claus Thestrup

CEO, Sweden

Latest content

Showing All content types
Ascelia Pharma: Wrap up on interview with CEO Magnus Corfitzen
Analyst Comment 21.09.2023 by Claus Thestrup
Ascelia Pharma
Ascelia Pharma - Update on re-evaluation of Sparkle headline data
Webcast 20.09.2023 by Claus Thestrup
Ascelia Pharma
Qlife: Wrap up from interview with CEO Thomas Warthoe
Analyst Comment 19.09.2023 by Claus Thestrup
Qlife Holding
Qlife - LOI with major industry player in China for Egoo Health
Webcast 19.09.2023 by Claus Thestrup
Qlife Holding
Qlife: LOI (Letter of intent) with major industry player in China for Egoo Health.
Analyst Comment 15.09.2023 by Claus Thestrup
Qlife Holding
Ascelia Pharma: Update on timeline and funding on Orviglance re-evaluation.
Analyst Comment 14.09.2023 by Henrik Ekman, Claus Thestrup
Ascelia Pharma
Bomill: New order from grain processor in Lithuania.
Analyst Comment 14.09.2023 by Claus Thestrup
BoMill
Bomill: Another distributing partner
Analyst Comment 13.09.2023 by Claus Thestrup
BoMill
Bomill: Adds new distributing partner in Canada
Analyst Comment 08.09.2023 by Claus Thestrup
BoMill
Gubra (One-pager): Unique high margin CRO business and a strong obesity portfolio in D&P
Research 08.09.2023 by Henrik Ekman, Philip Coombes, Claus Thestrup
Gubra